Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line

Physical Biology

Volumn 9, Issue 1, 2012, Pages

  Lazar, Daniel C ^a   Cho, Edward H ^a,d   Luttgen, Madelyn S ^a   Metzner, Thomas J ^a   Uson, Maria Loressa ^a   Torrey, Melissa ^b   Gross, Mitchell E ^c   Kuhn, Peter ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS CLINIC   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; CD45 ANTIGEN; INDOLE DERIVATIVE; KERATIN;

ADULT; ARTICLE; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR EMBOLISM;

ADULT; ANTIGENS, CD45; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INDOLES; KERATINS; MALE; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 84856952228     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/9/1/016002     Document Type: Article

References (20)

1. Eccles S A and Welch D R 2007 Metastasis: recent discoveries and novel treatment strategies Lancet 369 1742-57 (Pubitemid 46755391)
2. Chiang A C and Massagué J 2008 Molecular basis of metastasis N. Engl. J. Med. 359 2814-23
3. Hanahan D and Weinberg R A 2000 The hallmarks of cancer Cell 100 57-70 (Pubitemid 30046295)
4. Cristofanilli M et al 2004 Circulating tumor cells, disease progression, and survival in metastatic breast cancer N. Engl. J. Med. 351 781-91 (Pubitemid 39095313)
5. Nagrath S et al 2007 Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 450 1235-9
6. Lin H K et al 2010 Portable filter-based microdevice for detection and characterization of circulating tumor cells Clin. Cancer Res. 16 5011-8
7. Stott S L et al 2010 Isolation of circulating tumor cells using a microvortex-generating herringbone-chip Proc. Natl Acad. Sci. USA 107 18392-7
8. Xu T, Lu B, Tai Y C and Goldkorn A 2010 A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter Cancer Res. 70 6420-6
9. Marrinucci D, Bethel K, Lazar D, Fisher J, Huynh E, Clark P, Bruce R, Nieva J and Kuhn P 2010 Cytomorphology of circulating colorectal tumor cells: a small case series J. Oncol. 2010 861341 (Available at http://www.hindawi.com/ journals/jo/2010/861341/)
10. Horoszewicz J S, Leong S S, Kawinski E, Karr J P, Rosenthal H, Chu T M, Mirand E A and Murphy G P 1983 LNCaP model of human prostatic carcinoma Cancer Res. 43 1809-18 (Available at http://cancerres.aacrjournals.org/content/43/4/ 1809.long) (Pubitemid 13122588)
11. Marrinucci D, Bethel K, Luttgen M, Bruce R H, Nieva J and Kuhn P 2009 Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type Arch. Pathol. Lab. Med. 133 1468-71
12. Marrinucci D et al 2012 Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers Phys. Biol. 9 016003
13. Uva P, Lahm A, Sbardellati A, Grigoriadis A, Tutt A and de Rinaldis E 2010 Comparative Membranome expression analysis in primary tumors and derived cell lines PLoS One 5 e11742
14. Sobel R E and Sadar M D 2005 Cell lines used in prostate cancer research: a compendium of old and new lines - part 1 J. Urol. 173 342-59
15. Sobel R E and Sadar M D 2005 Cell lines used in prostate cancer research: a compendium of old and new lines - part 2 J. Urol. 173 360-72
16. Bissell M J and Hines W C 2011 Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression Nature Med. 17 320-9
17. Liu Z, Marquez M, Nilsson S and Holmberg A R 2009 Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin Oncol. Rep. 22 1451-8 (Available at http://www.spandidos- publications.com/or/22/6/1451)
18. Bockhorn M, Jain R K and Munn L L 2007 Active versus passive mechanisms in metastasis: Do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 8 444-8 (Pubitemid 46621773)
19. Rao C G, Chianese D, Doyle G V, Miller M C, Russell T, Sanders R A Jr and Terstappen L W 2005 Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors Int. J. Oncol. 27 49-57 (Available at http://www.spandidos-publications.com/ijo/27/1/49)
20. Paccione R J, Miyazaki H, Patel V, Waseem A, Gutkind J S, Zehner Z E and Yeudall W A 2008 Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol. Cancer Ther. 7 2894-903